- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0006687

Ajmera Pharmaceuticals Pvt Ltd
About Ajmera Pharmaceuticals Pvt Ltd
Data last updated:
Ajmera Pharmaceuticals Pvt Ltd is a private limited company based in Indore, Madhya Pradesh, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 18 June 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1992PTC007165. Its GSTIN is 23AACCA5282B1Z8 (Madhya Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Amar Ajmera and Paresh Ajmera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 9 A Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.15 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.4 Lakh (net margin 0.7%) and EBITDA of ₹30.83 Lakh (EBITDA margin 14.3%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
The company has about 32 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.69 Cr and satisfied charges of ₹1.66 Cr on record.
Ajmera Pharmaceuticals Pvt Ltd is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0006687). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Ajmera Pharmaceuticals
Contact details
Ajmera Pharmaceuticals Pvt Ltd's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressB – 9 A Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Ajmera Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ajmera Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ajmera Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Ajmera Pharmaceuticals Pvt Ltd
FY 2025 filings availableAjmera Pharmaceuticals Pvt Ltd reported revenue of ₹2.15 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ajmera Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Ajmera Pharmaceuticals Pvt Ltd
Ajmera Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Ajmera | Director | 01 May 2006 | 20 Years 5 Months | Current |
| Paresh Ajmera | Director | 01 Sep 2001 | 25 Years 1 Months | Current |
Auditor
Ajmera Pharmaceuticals Pvt Ltd is audited by M KHANDELWAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M KHANDELWAL & CO | FY 2021 | 000333C |
Shareholding
The shareholding of Ajmera Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ajmera Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2025 | 101082809 | Others | ₹1.69 Cr | Open | |
| 25 Jun 2013 | 10434147 | Hdfc Bank Limited | ₹45 Lakh | Satisfied | |
| 14 Mar 2012 | 10342122 | Madhya Pradesh Financial Corporation | ₹20 Lakh | Satisfied | |
| 22 Aug 2009 | 10172905 | Madhya Pradesh Financial Corporation | ₹50 Lakh | Satisfied | |
| 01 Feb 1999 | 90208363 | State Bank of Indore | ₹5 Lakh | Satisfied |
To see the full charge records of Ajmera Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 9 View all charges
Legal cases
No court or tribunal cases involving Ajmera Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ajmera Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ajmera Pharmaceuticals Pvt Ltd has a workforce of 32 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Ajmera Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCA5282B1Z8 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ajmera Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Ajmera Pharmaceuticals Pvt Ltd has 7 board changes on record since 2001: 2 appointments and 5 cessations. The latest: Shyam Ajmera ceased to be Director on 25 Feb 2012.
17 earlier events are in the company report.
Frequently asked questions
Ajmera Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 18 June 1992 (34+ years old) and is registered under CIN U24232MP1992PTC007165.
Ajmera Pharmaceuticals has 2 current directors:
- Amar Ajmera - Director
- Paresh Ajmera - Director
The latest financial statements of Ajmera Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ajmera Pharmaceuticals is 23AACCA5282B1Z8, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ajmera Pharmaceuticals is U24232MP1992PTC007165. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ajmera Pharmaceuticals was incorporated on 18 June 1992, making it 34+ years old. It is registered with the Registrar of Companies, Gwalior.
Shyam Ajmera ceased to be Director on 25 Feb 2012. Mukesh Ajmera ceased to be Director on 01 Nov 2010. Gaurav Ajmera ceased to be Director on 04 Jul 2009. Ajmera Pharmaceuticals has 7 board changes on record in total.
Yes, Ajmera Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0006687).
The registered office of Ajmera Pharmaceuticals is at B – 9 A Industrial Estate Pologround, Indore, Madhya Pradesh, India – 452015.
Ajmera Pharmaceuticals operates in the healthcare industry, in the ayurvedic products and services segment.